Rtw Investments »

Evommune shares owned by Rtw Investments

Quarter-by-quarter ownership of Evommune (EVMN) shares owned by Rtw Investments from 13F filings

Historical chart of Rtw Investments investment in Evommune

Tip: Access up to 7 years of quarterly data

All positions including Evommune held by Rtw Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evommune by Rtw Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $22M 1.3M 17.12

More positions owned by Rtw Investments

Madrigal Pharmaceuticals (MDGL)
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Argenx Se Sponsored Adr (ARGX)
Protagonist Therapeutics (PTGX)
Natera (NTRA)
RadNet (RDNT)
Tarsus Pharmaceuticals (TARS)
Cogent Biosciences (COGT)
Penumbra (PEN)
Irhythm Technologies (IRTC)
Apogee Therapeutics (APGE)
Apellis Pharmaceuticals (APLS)
ACADIA Pharmaceuticals (ACAD)
Establishment Labs Holdings Ord (ESTA)

View all positions for Rtw Investments

Top funds holding Evommune

EQT Fund Management S.a r.l.
Pivotal bioVenture Partners Investment Advisor
Nan Fung Group Holdings
Rtw Investments
Marshall Wace
Eventide Asset Management
Sectoral Asset Management
Verition Fund Management
Standard Life Aberdeen
Velan Capital Investment Management
Vanguard Group
Octagon Capital Advisors
American Century Companies
Federated Investors
Dr. Jeffrey R. Jay, M.D.

View all funds holding Evommune